Metrics Plus News Today

New data reveal that starting furoate/umeclidinium/vilanterol (FF/UMEC/VI) without delay not only significantly reduces exacerbations and health care costs but also enhances adherence and persistence for patients with chronic obstructive pulmonary disease (COPD) compared with other therapies.

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.

1. The adoption of medical artificial intelligence (AI) technologies has increased exponentially over the past few years, both in terms of total number of claims and the development of new current procedural terminology (CPT) medical AI procedures. 2. Medical AI technology usage was shown to be largely restricted to metropolitan areas and/or those with an

The retrospective cohort study evaluated data from 116 patients who received venetoclax as part of their first-line treatment and 145 patients in the relapsed/refractory setting..

Obesity is known to approximately double healthcare costs in the US compared to those with a healthy weight.

This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.

Most physicians start patients with H pylori infection on clarithromycin, despite high rates of resistance.

Americans who get seriously ill from COVID-19 in 2021 might have to pay thousands of dollars in bills from their hospitals, doctors and ambulance companies, a new study suggests. The new University of Michigan analysis, published in JAMA Network Open, has implications for both policymakers and people who haven't yet gotten vaccinated, as well as for people with underlying

The waivers are going away: People in the United States could face substantial costs if they end up in the hospital with severe COVID-19 in 2021.

Out-of-pocket costs could range from $1,500 to $3,800, depending on insurance.